Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to $1.2 million.

  • Utah Medical Products' Non-cash Items rose 32559.73% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 3225.81%. This contributed to the annual value of $52000.0 for FY2024, which is 400.0% up from last year.
  • Per Utah Medical Products' latest filing, its Non-cash Items stood at $1.2 million for Q3 2025, which was up 32559.73% from -$175000.0 recorded in Q2 2025.
  • Utah Medical Products' 5-year Non-cash Items high stood at $2.7 million for Q1 2023, and its period low was -$691000.0 during Q2 2024.
  • Over the past 5 years, Utah Medical Products' median Non-cash Items value was $1.3 million (recorded in 2021), while the average stood at $1.1 million.
  • As far as peak fluctuations go, Utah Medical Products' Non-cash Items plummeted by 19691.44% in 2024, and later soared by 32559.73% in 2025.
  • Over the past 5 years, Utah Medical Products' Non-cash Items (Quarter) stood at $1.6 million in 2021, then rose by 13.61% to $1.8 million in 2022, then plummeted by 97.24% to $50000.0 in 2023, then increased by 4.0% to $52000.0 in 2024, then surged by 2298.08% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, -$175000.0 for Q2 2025, and $1.4 million during Q1 2025.